NPR talks to Claire Hannan, who has helped navigate vaccine rollouts in all 50 states, about some of the challenges involved in quickly getting shots out to millions of young kids.
(Image credit: Joseph Prezioso/AFP via Getty Images)
SOURCE: Research News : NPR – Read entire story here.
Related posts:
- COVID Toddler Vax Clears Major Hurdle (MedPage Today) -- An advisory committee recommended that the FDA give emergency use authorization (EUA) to both Moderna and Pfizer/BioNTech's mRNA COVID-19 vaccines for infants, toddlers, and preschool kids. The Vaccines and Related Biological......
- FDA Advisers Back Authorization of Novavax COVID Shot (MedPage Today) -- The benefits of Novavax's adjuvanted protein-based COVID-19 vaccine outweigh the risks, the FDA's Vaccines and Related Biological Products Advisory Committee (VRBPAC) said in a near-unanimous vote on Tuesday. With 21 members......
- CDC’s Advisers Endorse COVID Vaccines in Youngest Kids (MedPage Today) -- The CDC's Advisory Committee on Immunization Practices (ACIP) voted unanimously on Saturday to recommend that children 6 months and older receive COVID-19 vaccines. As proposed by CDC staff, and now approved by CDC Director......
- KHN’s ‘What the Health?’: Closing In on Covid Vaccines for ‘The Littles’ Can’t see the audio player? Click here to listen on Acast. You can also listen on Spotify, Apple Podcasts, Stitcher, Pocket Casts, or wherever you listen to podcasts. Children younger than 5 are the only population not eligible for a covid-19 vaccine in the U.S. But that may be about to change as an advisory committee to the Food and Drug Administration recommends authorization for that group. Meanwhile, on Capitol Hill, senators are struggling to write into legislative language a tentative deal reached over the weekend on gun control and mental health, and the Supreme Court says no to certain...
- COVID mRNA Vaccines Safe, Effective for Babies and Toddlers, Says FDA Staff (MedPage Today) -- Moderna and Pfizer/BioNTech's COVID-19 vaccines proved safe and effective for kids under 5 years of age, paving the way for immunization of the only age group still awaiting access, according to FDA briefing documents released......